| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 28/08/2021 | DOC. 11021713 | Butantan/CoronaVac | 130 | 80 | 0 | 0 | 0 | 210 |
| 08/09/2021 | DOC. 11099863 | Fiocruz/Oxford/AstraZeneca | 0 | 385 | 0 | 0 | 0 | 385 |
| 08/09/2021 | DOC. 11099863 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 108 | 0 | 0 | 0 | 108 |
| 08/09/2021 | DOC. 11079134 | Butantan/CoronaVac | 230 | 60 | 0 | 0 | 0 | 290 |
| 13/09/2021 | doc.11123009 | Butantan/CoronaVac | 80 | 0 | 0 | 0 | 0 | 80 |
| 13/09/2021 | doc. 11154661 | Butantan/CoronaVac | 60 | 170 | 0 | 0 | 0 | 230 |
| 13/09/2021 | doc. 11154661 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 150 | 132 | 0 | 0 | 0 | 288 |
| 16/09/2021 | DOC. 11197168 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 138 | 0 | 0 | 0 | 0 | 138 |
| 16/09/2021 | DOC. 11197168 | Butantan/CoronaVac | 0 | 130 | 0 | 0 | 0 | 130 |
| 20/09/2021 | DOC. 11219951 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 348 | 0 | 0 | 0 | 0 | 348 |
| 21/09/2021 | DOC. 11253492 | Fiocruz/Oxford/AstraZeneca | 0 | 95 | 0 | 2 | 0 | 97 |
| 21/09/2021 | DOC. 11253492 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 126 | 0 | 0 | 0 | 126 |
| 21/09/2021 | DOC. 11253492 | Butantan/CoronaVac | 140 | 230 | 0 | 0 | 0 | 370 |
| 24/09/2021 | DOC.11283396 | Fiocruz/Oxford/AstraZeneca | 0 | 260 | 0 | 0 | 0 | 260 |
| 24/09/2021 | DOC.11283396 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 390 | 0 | 0 | 0 | 390 |
| 24/09/2021 | DOC.11305664 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 288 | 48 | 0 | 0 | 0 | 336 |
| 27/09/2021 | DOC.11305664 | Fiocruz/Oxford/AstraZeneca | 0 | 115 | 0 | 0 | 0 | 115 |
| 27/09/2021 | DOC. 11305761 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 12 |
| 30/09/2021 | DOC.11330717 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 120 | 0 | 0 | 0 | 120 |
| 30/09/2021 | DOC.11330725 | Butantan/CoronaVac | 100 | 0 | 0 | 0 | 0 | 100 |
| 04/10/2021 | DOC.11383750 | Butantan/CoronaVac | 0 | 10 | 0 | 0 | 0 | 10 |
| 04/10/2021 | DOC.11383750 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 306 | 0 | 0 | 0 | 306 |
| 04/10/2021 | DOC. 11383750 | Fiocruz/Oxford/AstraZeneca | 0 | 45 | 0 | 0 | 0 | 45 |
| 06/10/2021 | DOC. 11417441 | Fiocruz/Oxford/AstraZeneca | 0 | 220 | 0 | 0 | 0 | 220 |
| 06/10/2021 | DOC. 11417441 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 220 | 0 | 0 | 0 | 220 |
| 06/10/2021 | DOC. 11417441 | Butantan/CoronaVac | 0 | 80 | 0 | 0 | 0 | 80 |
| 08/10/2021 | DOC. 11432218 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 216 | 0 | 0 | 0 | 216 |
| 08/10/2021 | DOC. 11432218 | Butantan/CoronaVac | 0 | 60 | 0 | 0 | 0 | 60 |
| 08/10/2021 | DOC. 11432351 | Fiocruz/Oxford/AstraZeneca | 0 | 75 | 0 | 0 | 0 | 75 |
| 08/10/2021 | DOC. 11432351 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 395 |
